Acorda Therapeutics Inc – Strategy, SWOT and Corporate Finance Report

Acorda Therapeutics Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Acorda Therapeutics Inc (Acorda) is a biopharmaceutical company that discovers, develops, and commercializes therapies for treating patients with neurological disorders. Its portfolio encomppases marketed products for the treatment of multiple sclerosis (MS) and for the intermittent treatment of people with Parkinson’s taking carbidopa or levodopa who experience off episodes. It is also developing a pipeline of neurological therapies addressing a range of disorders, including migraine, MS, heart failure and spinal cord injury. The company sells its products through wholesale pharmaceutical distributors to retail pharmacies and specialty pharmacy providers. It has subsidiaries in the US and Europe. Acorda is headquartered in Ardsley, New York, the US.

Scope

Detailed information on Acorda Therapeutics Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Acorda Therapeutics Inc in the form of a SWOT analysis

An in-depth view of the business model of Acorda Therapeutics Inc including a breakdown and examination of key business segments

News about Acorda Therapeutics Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Acorda Therapeutics Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Acorda Therapeutics Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Acorda Therapeutics Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Biogen Inc

Amneal Pharmaceuticals Inc

Sandoz International GmbH

AbbVie Inc

Intec Pharma Ltd

Genzyme Corp

Newron Pharmaceuticals SpA

F. Hoffmann-La Roche Ltd

Teva Pharmaceutical Industries Ltd

Merck & Co Inc

Bayer AG

Adamas Pharmaceuticals Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Acorda Therapeutics Inc - Key Facts

Acorda Therapeutics Inc - Key Employees

Acorda Therapeutics Inc - Key Employee Biographies

Acorda Therapeutics Inc - Major Products and Services

Acorda Therapeutics Inc - History

Acorda Therapeutics Inc - Company Statement

Acorda Therapeutics Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Acorda Therapeutics Inc - Business Description

Product Category: Ampyra

Overview

Performance

Product Category: Inbrija

Overview

Product Category: Qutenza

Overview

Performance

Product Category: Net Product Revenue

Capital Expenditure

Product Category: Royalty Revenue

Performance

R&D Overview

Acorda Therapeutics Inc - Corporate Strategy

Acorda Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Acorda Therapeutics Inc - Strengths

Acorda Therapeutics Inc - Weaknesses

Acorda Therapeutics Inc - Opportunities

Acorda Therapeutics Inc - Threats

Acorda Therapeutics Inc - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Acorda Therapeutics Inc, Recent Deals Summary

Section 5 Company’s Recent Developments

Jun 03, 2019: Acorda Therapeutics Debuts Art Exhibition inspired by people with Parkinson’s at the 5th World Parkinson Congress

May 02, 2019: Acorda provides update for first quarter ended march 31, 2019

Mar 08, 2019: Acorda Therapeutics announces management changes

Feb 14, 2019: Acorda provides financial and pipeline update for fourth quarter and year end 2018

Feb 04, 2019: Acorda Therapeutics names Peter S. Carbone Senior Vice President, Quality

Jan 07, 2019: Acorda Provides 2018 highlights and 2019 guidance at J.P. Morgan Healthcare Conference

Dec 05, 2018: Acorda launches art initiative to foster better conversations about Parkinson's symptoms

Dec 05, 2018: Acorda launches art initiative to foster better conversations about Parkinson’s symptoms

Oct 31, 2018: Acorda provides financial and pipeline update for third quarter 2018

Aug 02, 2018: Acorda provides financial and pipeline update for second quarter 2018

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Acorda Therapeutics Inc, Key Facts

Acorda Therapeutics Inc, Key Employees

Acorda Therapeutics Inc, Key Employee Biographies

Acorda Therapeutics Inc, Major Products and Services

Acorda Therapeutics Inc, History

Acorda Therapeutics Inc, Other Locations

Acorda Therapeutics Inc, Subsidiaries

Acorda Therapeutics Inc, Key Competitors

Acorda Therapeutics Inc, Ratios based on current share price

Acorda Therapeutics Inc, Annual Ratios

Acorda Therapeutics Inc, Annual Ratios (Cont…1)

Acorda Therapeutics Inc, Annual Ratios (Cont…2)

Acorda Therapeutics Inc, Interim Ratios

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Acorda Therapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Acorda Therapeutics Inc, Performance Chart (2014 – 2018)

Acorda Therapeutics Inc, Ratio Charts

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports